If there is no real check on compounded drugs, doses can be wrong, there can be unwanted stuff in them, or they may be made where it's not clean
The single-center, double-blind, randomized, placebo-controlled trial in healthy postmenopausal women will study the safety, pharmacokinetics and change in biomarkers related to activin and GDF biology following subcutaneous administration of HS135
Lipid profile improvements (TRIUMPH-4): Non-HDL cholesterol: Clinically meaningful reduction Triglycerides: Significant reduction hsCRP (inflammatory marker): Significant reduction HDL cholesterol: Not significantly improved (consistent with Phase 2 findings) The triglyceride reduction is particularly notable and likely related to glucagon receptor activation, which enhances fat oxidation
We have seen this before: when access outpaces structured care, avoidable morbidity can overshadow efficacy
Its a brilliant question
Compounded semaglutide through Mixx at $120/month is the most affordable option available
